Table. 1.

The concentrations, RT, and RI of chemical composition of the OVA essential oil in different vegetation periods (compounds with concentration more than 1.0%)

Compound Pre-blossoming Blossoming Fruiting
Concentration (%) RT/RI Concentration (%) RT/RI Concentration (%) RT/RI
(+)-Sabinene 2.42 13.43/971 3.1 3.36/897 3.29 13.36/897
β-Pinene 2.06 15/983 - - - -
trans-β-Ocimene 6.13 18.37/1,041 3.81 19.35/978 2.61 18.4/1,042
3-Octanol - - 2.37 26.69/979 - -
2-Hexenal diethyl acetal, trans - - 3.27 21.22/993 - -
β-Ocimene 4.04 19.19/1,043 - - 5.97 19.27/1,050
ο-Cymene 2.22 20.32/1,045 5.22 20.43/1,045 9.41 20.33/1,045
Eucalyptol - - 1.95 17.7/1,059 4.18 17.68/1,037
α-Terpinolene - - - - 1.0 20.88/1,089
β-Linalool - - 2.90 34.26/1,083 1.18 34.21/1,100
trans-β-Terpineol 1.01 21.79/1,125 - - - -
Neo-allo-ocimene 1.65 25.35/1,131 - - - -
p-Menthan-3-one 1.18 30.43/1,275 - - - -
L-4-terpineol 2.19 37.14/1,335 2.34 37.19/1,137 2.18 37.12/1,137
cis-β-Terpineol - - 2.57 30.42/1,158 - -
Carvacrol/Isothymol - - 2.38 62.23/1,262 - -
α-Terpineol - - - - 1.74 41.53/1,181
(-)-β-Bourbonene - - 2.21 32.77/1,339 1.13 32.68/1,380
Dihydroedulan II - - 1.93 31.68/1,342 - -
Elixene 1.27 30.68/1,375 - - 1.75 42.89/1,375
β-Caryophyllene 7.0 36.7/1,417 8.18 36.9/1,494 6.41 36.62/1,410
γ-Elemene 1.18 42.89/1,433 - - - -
α-Humulene 1.68 39.97/1,456 2.68 40.06/1,456 1.53 39.93/1,455
I-β-Bisabolene - - 3.24 42.47/1,501 2.18 42.31/1,561
Germacrene D 3.80 41.83/1,482 3.80 41.92/1,515 9.22 41.8/1,515
β-Caryophyllene epoxide 5.6 53.91/1,517 13.36 54.18/1,517 11.2 53.91/1,517
cis-Z-α-Bisabolene epoxide 1.97 81.02/1,536 - - - -
Isoaromadendrene epoxide 3.72 82.25/1,579 - - - -
Ent-Spathulenol 6.75 59.2/1,590 3.77 59.26/1,536 2.51 59.15/1,590
tau-Cadinol 1.48 60.76/1,628 - - 1.53 60.75/1,628
α-Cadinol 6.9 61.41/1,652 - - 6.93 63.09/1,653
α-Humulene epoxide II - - 2.38 56.17/1,579 - -
Palmitic acid - - 2.52 84.11/1,968 - -

RT: retention times, RI: retention indexes, OVA: Origanum vulgare of the Armenian highlands.

Korean J Pain 2022;35:140~151 https://doi.org/10.3344/kjp.2022.35.2.140
© Korean J Pain